Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 294,700 shares, an increase of 8.1% from the May 31st total of 272,600 shares. Based on an average daily trading volume, of 123,600 shares, the short-interest ratio is presently 2.4 days.

Addus HomeCare Stock Up 0.4 %

Shares of Addus HomeCare stock opened at $116.65 on Wednesday. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $120.53. The company has a market capitalization of $1.91 billion, a P/E ratio of 28.95, a PEG ratio of 1.77 and a beta of 1.01. The business’s fifty day moving average price is $110.60 and its two-hundred day moving average price is $100.28. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same period last year, the firm earned $0.84 EPS. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. As a group, research analysts forecast that Addus HomeCare will post 4.36 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The transaction was disclosed in a document filed with the SEC, which is available at this link. 4.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds have recently modified their holdings of the company. Principal Securities Inc. acquired a new position in shares of Addus HomeCare during the 4th quarter valued at $26,000. GAMMA Investing LLC acquired a new position in shares of Addus HomeCare in the 4th quarter worth $34,000. EntryPoint Capital LLC acquired a new position in shares of Addus HomeCare in the 1st quarter worth $44,000. Assetmark Inc. grew its holdings in shares of Addus HomeCare by 33.3% in the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares during the last quarter. Finally, Mesirow Financial Investment Management Inc. acquired a new position in shares of Addus HomeCare in the 1st quarter worth $234,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on ADUS. Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. TD Cowen raised their price target on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a report on Tuesday, June 18th. Bank of America raised their price target on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Stephens raised their price target on Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a report on Friday, May 31st. Finally, Oppenheimer raised their price target on Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $116.25.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.